private financing
PreciseDx Raises $10.75M in Series A Round
The company is developing a cancer risk stratification technology that combines tissue-derived morphology information with clinical data.
Nucleix Raises Additional $22M
The Israeli molecular diagnostics firm is developing liquid biopsy tests for early-stage and recurring cancer detection based on methylation patterns.
Exai Bio Raises $67.5M in Series A Round for Liquid Biopsy Early Cancer Detection Platform
The blood-based platform uses AI and machine learning algorithms to analyze cell-free RNA profiles, with a focus on orphan noncoding RNA.
Acrivon Therapeutics Raises $100M in Series B Funding
The company will use the funds to advance its CHK1/2 inhibitor ACR-368 and use its proteomics platform to develop companion tests.
Blackstone Invests $250M in Cell Therapy Developer Autolus
The funds will help Autolus complete a Phase II trial of its lead CAR T-cell therapy in ALL, which is slated to readout next year.
Oct 14, 2021
Anticancer Bioscience Raises $31M in Seed Financing
Sep 17, 2021
Gritstone Bio Raises $55M in PIPE Financing
Jul 19, 2021
Frontier Medicines Nets $88.5M in Series B Funding
Jun 24, 2021
XCures Raises $12.7M in Series A Funding
May 11, 2021
Nuvalent Raises $135M in Series B Funding
Mar 16, 2021